Literature DB >> 2376755

Eosinophilic meningitis in Thailand. Clinical and epidemiological characteristics of 162 patients with myeloencephalitis probably caused by Gnathostoma spinigerum.

S Punyagupta1, T Bunnag, P Juttijudata.   

Abstract

The clinical and epidemiological characteristics of 162 patients with eosinophilic myeloencephalitis, believed to be caused by invasion of the central nervous system by Gnathostoma spinigerum, are described. The case mortality rate was at least 12%, and probably higher. Single live young adult G. spinigerum were recovered from the brains of 2 patients at autopsy and from the eye lids of 2 other living patients. The disease caused by this parasite can be distinguished from that caused by Angiostrongylus cantonensis by characteristic acute nerve root pain, signs of spinal cord and cerebral involvement, and the presence of bloody or xanthochromic cerebrospinal fluid. As judged by its prevalence and mortality, central nervous system disease caused by G. spinigerum is the most important parasitic disease of the central nervous system in Thailand. Since invasion of the nervous system by this parasite is a significant cause of intracranial hemorrhage in Thailand, it should be kept in mind by internists, neurologists, neurosurgeons, and pathologists who care for patients residing in, or who have visited, areas where G. spinigerum occurs.

Entities:  

Mesh:

Year:  1990        PMID: 2376755     DOI: 10.1016/0022-510x(90)90136-b

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Diagnostic importance of eosinophilic meningitis in HIV-positive and HIV-negative patients.

Authors:  Sérgio Monteiro de Almeida; Caroline Vieira de Souza; Letícia Pletsch; Sasha Keith Kovaliuk; Alfredo Hummelgen; Vitor Vieira Piseta; Crystal Rosiane Auersvald Haurani; Indiamara Saliane Mendes; Edna Yoshito Yamada; Ingrid Sampaio Fröehner; Rosangela Lameira Pinheiro; Adriana de Fátima Gabriel; Laura Lúcia Cogo; Lucas Nathã Almeida Lira; Mirian Su Mi Kim; Gisele M B Singer
Journal:  J Neurovirol       Date:  2019-01-23       Impact factor: 2.643

2.  Gnathostomiasis: Report of a case and brief review.

Authors:  S Houston
Journal:  Can J Infect Dis       Date:  1994-05

Review 3.  Neuroparasitic infections: nematodes.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

4.  The current status of laboratory diagnosis of Angiostrongylus cantonensis infections in humans using serologic and molecular methods.

Authors:  Patricia P Wilkins; Yvonne Qvarnstrom; A Christian Whelen; Caitlin Saucier; Alexandre J da Silva; Praphathip Eamsobhana
Journal:  Hawaii J Med Public Health       Date:  2013-06

Review 5.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

6.  Imported intraocular gnathostomiasis with subretinal tracks confirmed by western blot assay.

Authors:  Ji Ho Yang; Moosang Kim; Eung Suk Kim; Byoung-Kuk Na; Seung-Young Yu; Hyung-Woo Kwak
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

Review 7.  Eosinophilia in Infectious Diseases.

Authors:  Elise M O'Connell; Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

8.  Eosinophilic Meningitis.

Authors:  Trevor Slom; Stuart Johnson
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

Review 9.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

10.  Gnathostomiasis acquired by British tourists in Botswana.

Authors:  Joanna S Herman; Emma C Wall; Christoffer van-Tulleken; Peter Godfrey-Faussett; Robin L Bailey; Peter L Chiodini
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.